< BACK

 

Paul Bateman

Chief Executive Officer

​

Paul joined ProVerum as CEO in 2019. He has over 30 years’ experience in the medical device industry, the last 25 years of which have been working with ‘start-up’ companies, where he has raised over $100 million in funding (venture/capital markets) and overseen two exits. Prior to joining ProVerum, Paul was CEO of Novate Medical, leading the successful development of the Sentry bio-convertible IVC filter and subsequent acquisition of the company by BTG plc in September 2018. Prior to Novate, Paul was CEO of Genosis plc, where he led the successful IPO of the company on the AIM of the London Stock Exchange.